Bavituximab, known as TRWH-783, represents an unique treatment strategy targeting phosphatidylserine (PS). PS is usually an internal lipid present within cell membranes; however, it's frequently shown on the surface of https://opensocialfactory.com/story25673818/bavituximab-a-new-approach-to-malignant-therapy